These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 2276843

  • 1. Protective milk O antibodies induced in guinea pigs by parenteral Shigella ribosomal vaccine.
    Chernokhvostova EV, Lyubinskaya MM, Belkin ZP, Levenson VI.
    Int Arch Allergy Appl Immunol; 1990; 92(3):265-7. PubMed ID: 2276843
    [Abstract] [Full Text] [Related]

  • 2. Quantitative analysis of IgG class and subclass and IgA serum response to Shigella sonnei and Shigella flexneri 2a polysaccharides following vaccination with Shigella conjugate vaccines.
    Robin G, Keisari Y, Slepon R, Ashkenazi S, Cohen D.
    Vaccine; 1999 Aug 06; 17(23-24):3109-15. PubMed ID: 10462247
    [Abstract] [Full Text] [Related]

  • 3. Local immune response and protection in the guinea pig keratoconjunctivitis model following immunization with Shigella vaccines.
    Hartman AB, Van de Verg LL, Collins HH, Tang DB, Bendiuk NO, Taylor DN, Powell CJ.
    Infect Immun; 1994 Feb 06; 62(2):412-20. PubMed ID: 7507892
    [Abstract] [Full Text] [Related]

  • 4. [Local immunity in the parenteral immunization of guinea pigs with a ribosomal dysentery vaccine].
    Liubinskaia MM, Rukhadze EZ, Chernokhvostova EV, Levenson VI.
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Jul 06; (7):55-9. PubMed ID: 3901625
    [Abstract] [Full Text] [Related]

  • 5. Parenteral immunization with Shigella ribosomal vaccine elicits local IgA response and primes for mucosal memory.
    Levenson VI, Chernokhvostova EV, Lyubinskaya MM, Salamatova SA, Dzhikidze EK, Stasilevitch ZK.
    Int Arch Allergy Appl Immunol; 1988 Jul 06; 87(1):25-31. PubMed ID: 3049397
    [Abstract] [Full Text] [Related]

  • 6. Immunogenicity and protective efficacy offered by a ribosomal-based vaccine from Shigella flexneri 2a.
    Shim DH, Chang SY, Park SM, Jang H, Carbis R, Czerkinsky C, Uematsu S, Akira S, Kweon MN.
    Vaccine; 2007 Jun 15; 25(25):4828-36. PubMed ID: 17507120
    [Abstract] [Full Text] [Related]

  • 7. Protective ribosomal preparation from Shigella sonnei as a parenteral candidate vaccine.
    Levenson VI, Egorova TP, Belkin ZP, Fedosova VG, Subbotina JL, Rukhadze EZ, Dzhikidze EK, Stassilevich ZK.
    Infect Immun; 1991 Oct 15; 59(10):3610-8. PubMed ID: 1716612
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.
    Oaks EV, Turbyfill KR.
    Vaccine; 2006 Mar 20; 24(13):2290-301. PubMed ID: 16364513
    [Abstract] [Full Text] [Related]

  • 10. Shigella lipopolysaccharide antibodies in pediatric populations.
    Passwell JH, Freier S, Shor R, Farzam N, Block C, Lison M, Shiff E, Ashkenazi S.
    Pediatr Infect Dis J; 1995 Oct 20; 14(10):859-65. PubMed ID: 8584312
    [Abstract] [Full Text] [Related]

  • 11. Concentration of milk secretory immunoglobulin A against Shigella virulence plasmid-associated antigens as a predictor of symptom status in Shigella-infected breast-fed infants.
    Hayani KC, Guerrero ML, Morrow AL, Gomez HF, Winsor DK, Ruiz-Palacios GM, Cleary TG.
    J Pediatr; 1992 Dec 20; 121(6):852-6. PubMed ID: 1447644
    [Abstract] [Full Text] [Related]

  • 12. IpaD-loaded N-trimethyl Chitosan Nanoparticles Can Efficiently Protect Guinea Pigs against Shigella flexneri.
    Akbari MR, Saadati M, Honari H, Ghorbani HM.
    Iran J Immunol; 2019 Sep 20; 16(3):212-224. PubMed ID: 31552830
    [Abstract] [Full Text] [Related]

  • 13. Shigella-Specific Immune Profiles Induced after Parenteral Immunization or Oral Challenge with Either Shigella flexneri 2a or Shigella sonnei.
    Clarkson KA, Porter CK, Talaat KR, Frenck RW, Alaimo C, Martin P, Bourgeois AL, Kaminski RW.
    mSphere; 2021 Aug 25; 6(4):e0012221. PubMed ID: 34259559
    [Abstract] [Full Text] [Related]

  • 14. Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model.
    Barry EM, Wang J, Wu T, Davis T, Levine MM.
    Vaccine; 2006 May 01; 24(18):3727-34. PubMed ID: 16169130
    [Abstract] [Full Text] [Related]

  • 15. Cross-reactivity of Shigella flexneri serotype 2a O antigen antibodies following immunization or infection.
    Van De Verg LL, Bendiuk NO, Kotloff K, Marsh MM, Ruckert JL, Puryear JL, Taylor DN, Hartman AB.
    Vaccine; 1996 Aug 01; 14(11):1062-8. PubMed ID: 8879103
    [Abstract] [Full Text] [Related]

  • 16. [Parenteral use of a therapeutic vaccine in acute dysentery].
    Ermakova ZF.
    Sov Med; 1979 May 01; (5):83-6. PubMed ID: 377515
    [No Abstract] [Full Text] [Related]

  • 17. Shigella-specific antibodies in the first year of life among Zambian infants: A longitudinal cohort study.
    Chisenga CC, Bosomprah S, Simuyandi M, Mwila-Kazimbaya K, Chilyabanyama ON, Laban NM, Bialik A, Asato V, Meron-Sudai S, Frankel G, Cohen D, Chilengi R.
    PLoS One; 2021 May 01; 16(5):e0252222. PubMed ID: 34043697
    [Abstract] [Full Text] [Related]

  • 18. Immunogenic value of live, inactivated and cell-free dysentery vaccines.
    Meitert T, Sulea IT, Gogulescu L, Baron E, Tempea C, Istrati G.
    Acta Microbiol Acad Sci Hung; 1974 May 01; 21(1-2):103-7. PubMed ID: 4613127
    [No Abstract] [Full Text] [Related]

  • 19. Technological aspect of the production of live dysentery vaccines for oral administration.
    Denchev V, Nenkov P, Vitanov T, Sumerska T, Marinova S, Vassilev T, Panova I, Bratoeva M, Linde K.
    Acta Microbiol Hung; 1991 May 01; 38(2):121-6. PubMed ID: 1805499
    [Abstract] [Full Text] [Related]

  • 20. [Specificity of the protective action of a ribosomal Shigella vaccine and the absence of activity in the ribosomes from R mutants].
    Levenson VI, Rukhadze EZ, Belkin ZP, Essaulova ME.
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Oct 01; (10):55-9. PubMed ID: 2464261
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.